$8.98
-0.06-0.66%
At Close: -
$8.98
00.00%
After Hours: Sep 20, 4:00 PM EDT
15 minutes delayed
Ocular Therapeutix reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Ocular Therapeutix using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-07 | $-0.26 | $-0.22 | -18.2 % |
Mar 2024 | 2024-05-07 | $-0.28 | $-0.19 | -47.4 % |
Dec 2023 | 2024-03-11 | $-0.35 | $-0.30 | -16.7 % |
Sep 2023 | 2023-11-07 | $-0.25 | $-0.29 | 13.8 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-07 | $16.44M | $15.82M | 3.93 % |
Mar 2024 | 2024-05-07 | $14.77M | $15.41M | -4.13 % |
Dec 2023 | 2024-03-11 | $14.80M | $15.71M | -5.78 % |
Sep 2023 | 2023-11-07 | $15.08M | $15.25M | -1.11 % |
Ocular Therapeutix (OCUL) is scheduled to report earnings on November 5, 2024. The last reported earnings were for reported on August 7, 2024 for Q2.
The Actual EPS was $-0.26, which missed the estimate of $-0.22.
The Actual Revenue was $16.4M, which beat the estimate of $15.8M.
Browse earnings estimates, EPS, and revenue on all stocks.